TRACON Gets EMA Orphan Drug Designation Status For Its TRC105 In Soft Tissue Sarcoma
May 04, 2016 at 10:04 AM EDT
TRACON Pharmaceuticals (NASDAQ: TCON) revealed that the European Medicines Agency (EMA) has granted orphan drug designation status ...